TINAG Antikörper (Middle Region)
-
- Target Alle TINAG Antikörper anzeigen
- TINAG (Tubulointerstitial Nephritis Antigen (TINAG))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TINAG Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- VAADRIAIQS KGRYTANLSP QNLISCCAKN RHGCNSGSID RAWWYLRKRG
- Kreuzreaktivität (Details)
-
Species reactivity (expected):Bovine.
Species reactivity (tested):Human. - Aufreinigung
- Immunoaffinity column
- Immunogen
- Synthetic peptide directed towards the middle region of human TINAG
- Top Product
- Discover our top product TINAG Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Rekonstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store lyophilized at 2-8 °C for one month or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or (in aliquots) at -20 °C long term.
-
- Target
- TINAG (Tubulointerstitial Nephritis Antigen (TINAG))
- Andere Bezeichnung
- TINAG (TINAG Produkte)
- Hintergrund
- TINAG is a basement membrane glycoprotein initially identified as a target of antibodies in some forms of immunologically mediated tubulointerstitial nephritis.Synonyms: TIN-Ag, Tubulointerstitial nephritis antigen
- Molekulargewicht
- TINAG: 54 kDa
- Gen-ID
- 27283
- NCBI Accession
- NM_014464
-